Search Results
26 items found for "Debbie Hay"
Posts (7)
- 📰 GPCR Weekly News, April 24 to 30, 2023
Sakmar, Debbie L. Hay, Lukas Grätz, and more. Check out some of the latest GPCR discoveries below!
- Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
November 2021 "Nov. 15, 2021 LONDON – There’s not yet proof of the pudding, but Omass Therapeutics Ltd.’s new structure-based technology has passed a key test, in enabling the discovery of orally available small molecules aimed at intractable and poorly drugged membrane and complex-bound protein targets. The targets, including G protein-coupled receptors (GPCRs), intracellular protein complexes and solute carriers, are relevant to immunology indications and rare diseases with high unmet need." Read more at the source #DrGPCR #GPCR #IndustryNews
- Decoding β-Arrestins: from Structure to function
conformational changes for the binding to the same GPCR to mediate differential regulatory effects (Haider
Other Pages (19)
- Ep 26 with Dr. Debbie Hay
Debbie Hay About this episode Dr. Debbie Hay is presently a professor at the Department of Pharmacology and Toxicology at the University Debbie obtained a Ph.D. in Molecular Pharmacology from Imperial College London in the UK. Join me and learn more about Debbie’s career and what she learned through her experiences as a scientist Debbie Hay on the web LinkedIn Wikipedia University of Otago University of Auckland Google Scholar Pubmed
- About Dr. GPCR Podcast | Dr. GPCR Ecosystem
Debbie Hay, Dr. Randy Hall, tributes to Dr. Marc Caron with over 30 guests including Dr.
- GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis
Zhang , Chao-Fu Wang , Tong Yin , Shu Cheng , Hui-Juan Zhong , Shan-He Yu , Lu Jiang , Sheng-Yue Wang , Hai